Suzhou Hengruihongyuan Medical Technology Co. LTD
8
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
1 terminated/withdrawn out of 8 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
Role: lead
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
Role: lead
Interventional Left Ventricular Assist System for PCI in CHIP Patients
Role: lead
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
Role: lead
Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Role: lead
Endovenous Radiofrequency Ablation Closure System in the Treatment of Varicose Veins
Role: lead
Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures
Role: lead
Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
Role: lead
All 8 trials loaded